Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway

European Addiction Research

Volumn 20, Issue 2, 2014, Pages 59-65

  Karlstad, Øystein ^a   Furu, Kari ^a,c   Skurtveit, Svetlana ^a,b   Selmer, Randi ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Attention deficit hyperactivity disorder; Opioid maintenance; Pharmacoepidemiology; Prescribed drugs; Prescription database; Psychotropic medicines; Stimulants

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATOMOXETINE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; DEXAMPHETAMINE; HYPNOTIC AGENT; METHADONE; METHYLPHENIDATE; OPIATE; PRESCRIPTION DRUG; PSYCHOTROPIC AGENT; NALOXONE;

ADULT; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; DELAYED RELEASE FORMULATION; DRUG USE; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION; PRESCRIPTION; PRIORITY JOURNAL; REFERENCE DATABASE; SEX DIFFERENCE; SUBSTANCE ABUSE; YOUNG ADULT; CONTROLLED STUDY; NARCOLEPSY; OPIOID MAINTENANCE TREATMENT; PREVALENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BUPRENORPHINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; METHADONE; NALOXONE; NORWAY; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896136978     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000353969     Document Type: Article

References (27)

1. Lee SS, Humphreys KL, Flory K, Liu R, Glass K: Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011; 31: 328-341.
2. Charach A, Yeung E, Climans T, Lillie E: Childhood attention-deficit/ hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 2011; 50: 9-21.
3. Vidal SI, Vandeleur C, Rothen S, Gholam-Rezaee M, Castelao E, Halfon O, Aubry JM, Ferrero F, Preisig M: Risk of mental disorders in children of parents with alcohol or heroin dependence: a controlled high-risk study. Eur Addict Res 2012; 18: 253-264.
4. Wilens TE: Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 2004; 27: 283-301. (Pubitemid 38452768)
5. Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T: Attention-deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis 1997; 185.
6. Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T: Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998; 44: 269-273. (Pubitemid 28389712)
7. Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, Farrer L, Kranzler HR: Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav 2008; 33: 1199-1207.
8. Mariani JJ, Levin FR: Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict 2007; 16: 45-56. (Pubitemid 46633919)
9. King VL, Brooner RK, Kidorf MS, Stoller KB, Mirsky AF: Attention-deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis 1999; 187: 487-495. (Pubitemid 29422603)
10. Wilens TE, Kwon A, Tanguay S, Chase R, Moore H, Faraone SV, Biederman J: Characteristics of adults with attention-deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict 2005; 14: 319-327. (Pubitemid 41318270)
11. Carpentier PJ, van Gogh MT, Knapen LJ, Buitelaar JK, De Jong CA: Influence of attention-deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res 2011; 17: 10-20.
12. Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV: Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 2006; 81: 137-148. (Pubitemid 41821797)
13. Blix O, Dalteg A, Nilsson P: Treatment of opioid dependence and ADHD/ADD with opioid maintenance and central stimulants. Heroin Addict Relat Clin Probl 2009; 11: 5-14.
14. Svarstad S, Dahl T: In Løvaas EK (ed): Erfaringsrapport fra nasjonal konferanse om: Kombinasjonsbehandling med sentralstimulerende medikament for pasienter med ADHD som mottar legemiddelassistert rehabilitering (LAR). Bergen, Stiftelsen Bergensklinikkene, 2010.
15. Waal H: Merits and problems in high-threshold methadone maintenance treatment: evaluation of medication-assisted rehabilitation in Norway 1998-2004. Eur Addict Res 2007; 13: 66-73.
16. Ministry of Health and Care Services: Forskrift om legemiddelassistert rehabilitering (LAR-forskriften). Oslo, MHCS, 2009.
17. Norwegian Directorate of Health: Nasjonal retningslinje for legemiddelassistert rehabilitering ved opioidavhengighet. Oslo, Nasjonale faglige retningslinjer, 2010.
18. Waal H, Clausen T, Håseth A, Lillevold PH: The 2010 annual assessment of the Norwegian OMT programme (in Norwegian). Oslo, SERAF-Norwegian Centre for Addiction Research, University of Oslo, 2011.
19. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sorensen HT: The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010; 106: 86-94.
20. WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC Classification and DDD Assignment. Oslo, WHO, 2011.
21. Fredheim OM, Moksnes K, Borchgrevink PC, Skurtveit S: Opioid switching to methadone: a pharmacoepidemiological study from a national prescription database. Palliat Med 2012; 26: 804-812.
22. Norwegian Directorate of Health: Veileder i diagnostikk og behandling av AD/HD. Oslo, Norway, 2005.
23. Van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA: Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012; 122: 11-19.
24. Norwegian Prescription Database (NorPD): Online report tool. Accessed March 22, 2012.
25. Hartz I, Bramness JG, Skurtveit S: Prescription of antidepressants to patients on opioid maintenance therapy-a pharmacoepidemiological study. Nor J Epidemiol 2011; 21: 77-84.
26. Fredheim OM, Borchgrevink PC, Nordstrand B, Clausen T, Skurtveit S: Prescription of analgesics to patients in opioid maintenance therapy: a pharmacoepidemiological study. Drug Alcohol Depend 2011; 116: 158-162.
27. Bramness JG, Kornør H: Benzodiazepine prescription for patients in opioid maintenance treatment in Norway. Drug Alcohol Depend 2007; 90: 203-209. (Pubitemid 47299170)